Virus-like Particles Produced in Plants: A Promising Platform for Recombinant Vaccine Development

Virus-like Particles Produced in Plants: A Promising Platform for Recombinant Vaccine Development

The capsid proteins of many viruses are capable of spontaneous self-assembly into virus-like particles (VLPs), which do not contain the viral genome and are therefore not infectious. VLPs are structurally similar to their parent viruses and are therefore effectively recognized by the immune system a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Eugenia S. Mardanova, Egor A. Vasyagin, Nikolai V. Ravin
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Plants
Subjects:	plant biofactory vaccine virus-like particle transient expression
Online Access:	https://www.mdpi.com/2223-7747/13/24/3564
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design and assembly of plant-based COVID-19 candidate vaccines: reсent development and future prospects
by: E. A. Uvarova, et al.
Published: (2022-06-01)

Chimeric Virus-like Particles of Physalis Mottle Virus as Carriers of M2e Peptides of Influenza a Virus
by: Elena A. Blokhina, et al.
Published: (2024-11-01)

A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine
by: Dan Xu, et al.
Published: (2024-11-01)

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
by: Weisen Ning, et al.
Published: (2025-01-01)

Tailored culture strategies to promote antimicrobial secondary metabolite production in Diaporthe caliensis: a metabolomic approach
by: Laura V. Hoyos, et al.
Published: (2024-12-01)

Potentiating Virus-like Particles for Mucosal Vaccination Using Material Science Approaches
by: Milad Radiom
Published: (2024-12-01)

Strengthening global health resilience: Marburg virus-like particle vaccines and the One Health approach
by: Ram Bahadur Khadka, et al.
Published: (2024-01-01)

Multifaceted virus-like particles: Navigating towards broadly effective influenza A virus vaccines
by: Jaffar Ali Muhamad Norizwan, et al.
Published: (2025-01-01)

Plant-Based Antigen Production Strategy for SARS-CoV-2 Nucleoprotein and RBD and Its Application for Detection of Antibody Responses in COVID-19 Patients
by: Katerina Takova, et al.
Published: (2025-01-01)

A novel platform for engineered AAV-based vaccines
by: Sabrina Babutzka, et al.
Published: (2025-03-01)

Simplified MS2 phage-like particle production including a novel maturation protein internal fusion affinity tag
by: Enos C. Kline, et al.
Published: (2025-12-01)

Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
by: Vladislav A. Lapin, et al.
Published: (2024-11-01)

Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in Egypt
by: Ahmed A. Ali, et al.
Published: (2025-01-01)

A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats and dogs
by: Xianyong Meng, et al.
Published: (2024-12-01)

A single immunization with H5N1 virus-like particle vaccine protects chickens against divergent H5N1 influenza viruses and vaccine efficacy is determined by adjuvant and dosage
by: Dexin Kong, et al.
Published: (2024-12-01)

A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice
by: Jie Liu, et al.
Published: (2024-12-01)

Enhanced Immunogenicity of Foot-and-Mouth Disease Virus-like Particles Using a Water-in-Oil-in-Water Adjuvant
by: Yujie Zhou, et al.
Published: (2024-12-01)

Optimising plant form and function for controlled environment agriculture in space and on earth
by: Muhammad Kamran, et al.
Published: (2023-09-01)

Expression of Toll-like Receptor Genes and Antiviral Cytokines in Macrophage-like Cells in Response to Indole-3-carboxylic Acid Derivative
by: Alexander Narovlyansky, et al.
Published: (2024-10-01)

Second-Generation Phage Lambda Platform Employing SARS-CoV-2 Fusion Proteins as a Vaccine Candidate
by: Alexis Catala, et al.
Published: (2024-10-01)

M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity
by: Furui Zhang, et al.
Published: (2025-01-01)

Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles
by: Grace Neilsen, et al.
Published: (2024-12-01)

Prognostic value of remnant-like particle cholesterol in ischemic heart failure patients following percutaneous coronary intervention
by: Xin Huang, et al.
Published: (2025-12-01)

A Pool of Bacterium-like Particles Displaying African Swine Fever Virus Antigens Induces Both Humoral and Cellular Immune Responses in Pigs
by: Jingshan Huang, et al.
Published: (2024-12-01)

IAPSM’s Position Paper on the Human Papilloma Virus (HPV) Vaccine for Adult Immunization in India
by: Ranjitha S. Shetty, et al.
Published: (2024-12-01)

Interferon-γ production in response to the cytotoxic T lymphocyte epitope within an antigen incorporated in simian virus 40 virus-like particles
by: Takeharu Watanabe, et al.
Published: (2025-01-01)

Oral Immunisation With Non‐GMO Surface Displayed SARS‐CoV‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice
by: Robie Vasquez, et al.
Published: (2025-01-01)

Significant Improvement in Magnetorheological Performance by Controlling Micron Interspaces with High Permeability Submicron Particles
by: Tianxiang Du, et al.
Published: (2024-11-01)

Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites
by: Ciying Qian, et al.
Published: (2025-01-01)

Neoadjuvant immunochemotherapy—a promising strategy for primary pulmonary lymphoepithelioma-like carcinoma
by: Jiawei Chen, et al.
Published: (2024-12-01)

Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults
by: Geert Leroux-Roels, et al.
Published: (2025-01-01)

Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial
by: Xavier Sáez-Llorens, et al.
Published: (2025-12-01)

Reconfiguration and Analysis of PV Array based on Particle Swarm Optimization of Solar Plant
by: Sheryar Muhammad, et al.
Published: (2022-06-01)

An effectively protective VLP vaccine candidate for both genotypes of feline calicivirus
by: Yupeng Yang, et al.
Published: (2024-12-01)

Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines
by: Lee Sherry, et al.
Published: (2025-01-01)

BPAP induces autism-like behavior by affecting the expression of neurodevelopmental genes in Drosophila melanogaster
by: Yuanyuan Song, et al.
Published: (2024-12-01)

Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
by: Hua Shi, et al.
Published: (2024-12-01)

McHDV VP60 Virus-like Particles Elicit Protective Immunity Against <i>Moschus chrysogaster</i> Hemorrhagic Disease in Rabbits
by: Yu Shao, et al.
Published: (2024-10-01)

Systematic analysis and functional characterization of the chitinase gene family in Fagopyrum tataricum under salt stress
by: Qingqing Li, et al.
Published: (2024-12-01)

Development of chimeric MrNV virus-like particles capable of binding to SARS-CoV-2-susceptible cells and reducing infection by pseudovirus variants
by: Supawich Boonkua, et al.
Published: (2024-12-01)